Two-Pronged attack: new combo therapy targets blood cancer
NCT ID NCT05410418
Summary
This study is testing a new combination of two drugs for people with follicular lymphoma who have not yet received any treatment. The goal is to see how well the drugs work together to shrink or eliminate the cancer. One drug helps the body's immune cells find and kill cancer cells, while the other delivers a cancer-killing drug directly to the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.